PAAG-OA

DEVICE2 trials

Sponsors

Contura

Conditions

Osteoarthritis, Knee

Unknown Phase

Treatment of Knee Osteoarthritis With PAAG-OA

Active, not recruitingNCT04045431

ConturaOsteoarthritis, Knee

Start: 2019-05-15End: 2026-11-30Target: 238Updated: 2024-01-08

PAAG-OA Treatment for Knee Osteoarthritis

CompletedNCT04179552

ConturaOsteoarthritis, Knee

Start: 2019-08-21End: 2024-09-19Updated: 2024-11-26

Related Papers

Sustained symptom relief and safety over five years following a single intra-articular injection of 2.5[%] polyacrylamide hydrogel in patients with knee osteoarthritis.

2026-03-04

A prospective, open-label, clinical investigation of a single intra-articular polyacrylamide hydrogel injection in participants with knee osteoarthritis: a 5-year extension study.

2025-12-12

Three-year follow-up from a randomised controlled trial of a single intra-articular polyacrylamide hydrogel injection in subjects with knee osteoarthritis.

2025-12-11

Effectiveness and safety of polyacrylamide hydrogel injection for knee osteoarthritis: results from a 12-month follow up of an open-label study

Journal of Orthopaedic Surgery and Research2024-05-0212 citations